Correspondingly, the detection of a TERT promotor mutation now qualifies the diagnosis of anaplasia [4] according to the current fifth edition of the WHO Classification of Central Nervous System Tumours [4], with potential subsequent impact on postoperative treatment. The gene discussed is TERT; the disease is central nervous system cancer.